img

Global Antidiabetic Thiazolidinediones Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antidiabetic Thiazolidinediones Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antidiabetic Thiazolidinediones report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antidiabetic Thiazolidinediones market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antidiabetic Thiazolidinediones industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antidiabetic Thiazolidinediones key manufacturers include Sanofi, Takeda Pharmaceuticals, Eli Lilly, Merck & Co., Novo Nordisk, Bristol-Myers Squibb, Pfizer, AstraZeneca and GlaxoSmithKline, etc. Sanofi, Takeda Pharmaceuticals, Eli Lilly are top 3 players and held % sales share in total in 2022.
Antidiabetic Thiazolidinediones can be divided into Rosiglitazone and Pioglitazone, etc. Rosiglitazone is the mainstream product in the market, accounting for % sales share globally in 2022.
Antidiabetic Thiazolidinediones is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Antidiabetic Thiazolidinediones industry development. In 2022, global % sales of Antidiabetic Thiazolidinediones went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antidiabetic Thiazolidinediones market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Takeda Pharmaceuticals
Eli Lilly
Merck & Co.
Novo Nordisk
Bristol-Myers Squibb
Pfizer
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim
Segment by Type
Rosiglitazone
Pioglitazone

Segment by Application


Hospitals
Clinics
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antidiabetic Thiazolidinediones market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antidiabetic Thiazolidinediones, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antidiabetic Thiazolidinediones industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antidiabetic Thiazolidinediones in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antidiabetic Thiazolidinediones introduction, etc. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antidiabetic Thiazolidinediones market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Antidiabetic Thiazolidinediones Market Overview
1.1 Antidiabetic Thiazolidinediones Product Overview
1.2 Antidiabetic Thiazolidinediones Market Segment by Type
1.2.1 Rosiglitazone
1.2.2 Pioglitazone
1.3 Global Antidiabetic Thiazolidinediones Market Size by Type
1.3.1 Global Antidiabetic Thiazolidinediones Market Size Overview by Type (2018-2034)
1.3.2 Global Antidiabetic Thiazolidinediones Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antidiabetic Thiazolidinediones Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidiabetic Thiazolidinediones Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antidiabetic Thiazolidinediones Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antidiabetic Thiazolidinediones Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antidiabetic Thiazolidinediones Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antidiabetic Thiazolidinediones Sales Breakdown by Type (2018-2024)
2 Global Antidiabetic Thiazolidinediones Market Competition by Company
2.1 Global Top Players by Antidiabetic Thiazolidinediones Sales (2018-2024)
2.2 Global Top Players by Antidiabetic Thiazolidinediones Revenue (2018-2024)
2.3 Global Top Players by Antidiabetic Thiazolidinediones Price (2018-2024)
2.4 Global Top Manufacturers Antidiabetic Thiazolidinediones Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic Thiazolidinediones Market Competitive Situation and Trends
2.5.1 Antidiabetic Thiazolidinediones Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidiabetic Thiazolidinediones Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2022)
2.7 Date of Key Manufacturers Enter into Antidiabetic Thiazolidinediones Market
2.8 Key Manufacturers Antidiabetic Thiazolidinediones Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidiabetic Thiazolidinediones Status and Outlook by Region
3.1 Global Antidiabetic Thiazolidinediones Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antidiabetic Thiazolidinediones Historic Market Size by Region
3.2.1 Global Antidiabetic Thiazolidinediones Sales in Volume by Region (2018-2024)
3.2.2 Global Antidiabetic Thiazolidinediones Sales in Value by Region (2018-2024)
3.2.3 Global Antidiabetic Thiazolidinediones Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antidiabetic Thiazolidinediones Forecasted Market Size by Region
3.3.1 Global Antidiabetic Thiazolidinediones Sales in Volume by Region (2024-2034)
3.3.2 Global Antidiabetic Thiazolidinediones Sales in Value by Region (2024-2034)
3.3.3 Global Antidiabetic Thiazolidinediones Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antidiabetic Thiazolidinediones by Application
4.1 Antidiabetic Thiazolidinediones Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Antidiabetic Thiazolidinediones Market Size by Application
4.2.1 Global Antidiabetic Thiazolidinediones Market Size Overview by Application (2018-2034)
4.2.2 Global Antidiabetic Thiazolidinediones Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antidiabetic Thiazolidinediones Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidiabetic Thiazolidinediones Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antidiabetic Thiazolidinediones Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antidiabetic Thiazolidinediones Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antidiabetic Thiazolidinediones Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antidiabetic Thiazolidinediones Sales Breakdown by Application (2018-2024)
5 North America Antidiabetic Thiazolidinediones by Country
5.1 North America Antidiabetic Thiazolidinediones Historic Market Size by Country
5.1.1 North America Antidiabetic Thiazolidinediones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antidiabetic Thiazolidinediones Sales in Volume by Country (2018-2024)
5.1.3 North America Antidiabetic Thiazolidinediones Sales in Value by Country (2018-2024)
5.2 North America Antidiabetic Thiazolidinediones Forecasted Market Size by Country
5.2.1 North America Antidiabetic Thiazolidinediones Sales in Volume by Country (2024-2034)
5.2.2 North America Antidiabetic Thiazolidinediones Sales in Value by Country (2024-2034)
6 Europe Antidiabetic Thiazolidinediones by Country
6.1 Europe Antidiabetic Thiazolidinediones Historic Market Size by Country
6.1.1 Europe Antidiabetic Thiazolidinediones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antidiabetic Thiazolidinediones Sales in Volume by Country (2018-2024)
6.1.3 Europe Antidiabetic Thiazolidinediones Sales in Value by Country (2018-2024)
6.2 Europe Antidiabetic Thiazolidinediones Forecasted Market Size by Country
6.2.1 Europe Antidiabetic Thiazolidinediones Sales in Volume by Country (2024-2034)
6.2.2 Europe Antidiabetic Thiazolidinediones Sales in Value by Country (2024-2034)
7 Asia-Pacific Antidiabetic Thiazolidinediones by Region
7.1 Asia-Pacific Antidiabetic Thiazolidinediones Historic Market Size by Region
7.1.1 Asia-Pacific Antidiabetic Thiazolidinediones Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antidiabetic Thiazolidinediones Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antidiabetic Thiazolidinediones Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antidiabetic Thiazolidinediones Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidiabetic Thiazolidinediones Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antidiabetic Thiazolidinediones Sales in Value by Region (2024-2034)
8 Latin America Antidiabetic Thiazolidinediones by Country
8.1 Latin America Antidiabetic Thiazolidinediones Historic Market Size by Country
8.1.1 Latin America Antidiabetic Thiazolidinediones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antidiabetic Thiazolidinediones Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antidiabetic Thiazolidinediones Sales in Value by Country (2018-2024)
8.2 Latin America Antidiabetic Thiazolidinediones Forecasted Market Size by Country
8.2.1 Latin America Antidiabetic Thiazolidinediones Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antidiabetic Thiazolidinediones Sales in Value by Country (2024-2034)
9 Middle East and Africa Antidiabetic Thiazolidinediones by Country
9.1 Middle East and Africa Antidiabetic Thiazolidinediones Historic Market Size by Country
9.1.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antidiabetic Thiazolidinediones Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antidiabetic Thiazolidinediones Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antidiabetic Thiazolidinediones Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antidiabetic Thiazolidinediones Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Antidiabetic Thiazolidinediones Products Offered
10.1.5 Sanofi Recent Development
10.2 Takeda Pharmaceuticals
10.2.1 Takeda Pharmaceuticals Company Information
10.2.2 Takeda Pharmaceuticals Introduction and Business Overview
10.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Products Offered
10.2.5 Takeda Pharmaceuticals Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly Antidiabetic Thiazolidinediones Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Company Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co. Antidiabetic Thiazolidinediones Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Information
10.5.2 Novo Nordisk Introduction and Business Overview
10.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Products Offered
10.5.5 Novo Nordisk Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Antidiabetic Thiazolidinediones Products Offered
10.7.5 Pfizer Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AstraZeneca Antidiabetic Thiazolidinediones Products Offered
10.8.5 AstraZeneca Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Boehringer Ingelheim
10.10.1 Boehringer Ingelheim Company Information
10.10.2 Boehringer Ingelheim Introduction and Business Overview
10.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Products Offered
10.10.5 Boehringer Ingelheim Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidiabetic Thiazolidinediones Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidiabetic Thiazolidinediones Industrial Chain Analysis
11.4 Antidiabetic Thiazolidinediones Market Dynamics
11.4.1 Antidiabetic Thiazolidinediones Industry Trends
11.4.2 Antidiabetic Thiazolidinediones Market Drivers
11.4.3 Antidiabetic Thiazolidinediones Market Challenges
11.4.4 Antidiabetic Thiazolidinediones Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidiabetic Thiazolidinediones Distributors
12.3 Antidiabetic Thiazolidinediones Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rosiglitazone
Table 2. Major Company of Pioglitazone
Table 3. Global Antidiabetic Thiazolidinediones Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US& Million)
Table 7. Global Antidiabetic Thiazolidinediones Market Share in Value by Type (2018-2024)
Table 8. Global Antidiabetic Thiazolidinediones Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Antidiabetic Thiazolidinediones Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Antidiabetic Thiazolidinediones Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Type (2024-2034)
Table 13. Global Antidiabetic Thiazolidinediones Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Antidiabetic Thiazolidinediones Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Antidiabetic Thiazolidinediones Sales Share by Company (2018-2024)
Table 26. Global Antidiabetic Thiazolidinediones Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Antidiabetic Thiazolidinediones Revenue Share by Company (2018-2024)
Table 28. Global Market Antidiabetic Thiazolidinediones Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Antidiabetic Thiazolidinediones Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Antidiabetic Thiazolidinediones Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2022)
Table 32. Date of Key Manufacturers Enter into Antidiabetic Thiazolidinediones Market
Table 33. Key Manufacturers Antidiabetic Thiazolidinediones Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antidiabetic Thiazolidinediones Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Antidiabetic Thiazolidinediones Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Antidiabetic Thiazolidinediones Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Region (2018-2024)
Table 40. Global Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Antidiabetic Thiazolidinediones Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Antidiabetic Thiazolidinediones Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Region (2024-2034)
Table 45. Global Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Antidiabetic Thiazolidinediones Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Application (2018-2024)
Table 51. Global Antidiabetic Thiazolidinediones Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Antidiabetic Thiazolidinediones Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Antidiabetic Thiazolidinediones Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Application (2024-2034)
Table 56. Global Antidiabetic Thiazolidinediones Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Antidiabetic Thiazolidinediones Sales by Application (2018-2024) (K Pcs)
Table 58. North America Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Antidiabetic Thiazolidinediones Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Antidiabetic Thiazolidinediones Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2018-2024)
Table 71. North America Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Antidiabetic Thiazolidinediones Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Sanofi Antidiabetic Thiazolidinediones Product
Table 111. Sanofi Recent Development
Table 112. Takeda Pharmaceuticals Company Information
Table 113. Takeda Pharmaceuticals Introduction and Business Overview
Table 114. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product
Table 116. Takeda Pharmaceuticals Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Introduction and Business Overview
Table 119. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Eli Lilly Antidiabetic Thiazolidinediones Product
Table 121. Eli Lilly Recent Development
Table 122. Merck & Co. Company Information
Table 123. Merck & Co. Introduction and Business Overview
Table 124. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Merck & Co. Antidiabetic Thiazolidinediones Product
Table 126. Merck & Co. Recent Development
Table 127. Novo Nordisk Company Information
Table 128. Novo Nordisk Introduction and Business Overview
Table 129. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Novo Nordisk Antidiabetic Thiazolidinediones Product
Table 131. Novo Nordisk Recent Development
Table 132. Bristol-Myers Squibb Company Information
Table 133. Bristol-Myers Squibb Introduction and Business Overview
Table 134. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product
Table 136. Bristol-Myers Squibb Recent Development
Table 137. Pfizer Company Information
Table 138. Pfizer Introduction and Business Overview
Table 139. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Pfizer Antidiabetic Thiazolidinediones Product
Table 141. Pfizer Recent Development
Table 142. AstraZeneca Company Information
Table 143. AstraZeneca Introduction and Business Overview
Table 144. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. AstraZeneca Antidiabetic Thiazolidinediones Product
Table 146. AstraZeneca Recent Development
Table 147. GlaxoSmithKline Company Information
Table 148. GlaxoSmithKline Introduction and Business Overview
Table 149. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. GlaxoSmithKline Antidiabetic Thiazolidinediones Product
Table 151. GlaxoSmithKline Recent Development
Table 152. Boehringer Ingelheim Company Information
Table 153. Boehringer Ingelheim Introduction and Business Overview
Table 154. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Boehringer Ingelheim Antidiabetic Thiazolidinediones Product
Table 156. Boehringer Ingelheim Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Antidiabetic Thiazolidinediones Market Trends
Table 160. Antidiabetic Thiazolidinediones Market Drivers
Table 161. Antidiabetic Thiazolidinediones Market Challenges
Table 162. Antidiabetic Thiazolidinediones Market Restraints
Table 163. Antidiabetic Thiazolidinediones Distributors List
Table 164. Antidiabetic Thiazolidinediones Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Thiazolidinediones Product Picture
Figure 2. Global Antidiabetic Thiazolidinediones Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antidiabetic Thiazolidinediones Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antidiabetic Thiazolidinediones Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Rosiglitazone
Figure 6. Global Rosiglitazone Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Pioglitazone
Figure 8. Global Pioglitazone Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Antidiabetic Thiazolidinediones Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Antidiabetic Thiazolidinediones Sales Market Share by Type in 2022 & 2034
Figure 11. North America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type in 2022
Figure 12. North America Antidiabetic Thiazolidinediones Sales Market Share in Value by Type in 2022
Figure 13. Europe Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type in 2022
Figure 14. Europe Antidiabetic Thiazolidinediones Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Value by Type in 2022
Figure 17. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Thiazolidinediones Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Thiazolidinediones Revenue in 2022
Figure 23. Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Antidiabetic Thiazolidinediones Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Antidiabetic Thiazolidinediones Sales Market Share by Application in 2022 & 2034
Figure 32. North America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application in 2022
Figure 33. North America Antidiabetic Thiazolidinediones Sales Market Share in Value by Application in 2022
Figure 34. Europe Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application in 2022
Figure 35. Europe Antidiabetic Thiazolidinediones Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Antidiabetic Thiazolidinediones Sales Market Share in Value by Application in 2022
Figure 38. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Antidiabetic Thiazolidinediones Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Antidiabetic Thiazolidinediones Manufacturing Cost Structure
Figure 43. Antidiabetic Thiazolidinediones Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries